-+ 0.00%
-+ 0.00%
-+ 0.00%

ASTRAZENECA: FIRST GLOBAL PHASE III TRIAL TO SHOW SIGNIFICANT PROGRESSION-FREE AND OVERALL SURVIVAL BENEFITS IN THIS SETTING

Reuters·08/17/2026 11:00:01

Please log in to view news